# The Effect of Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery

> **NCT06139666** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **The Cooper Health System** · enrollment: 160 (estimated)

## Conditions studied

- Rotator Cuff Tears
- Postoperative Pain
- Opioid Use

## Interventions

- **DRUG:** Exparel Injectable Solution
- **DRUG:** Bupivacaine Injectable Solution

## Key facts

- **NCT ID:** NCT06139666
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-07-11
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139666, "The Effect of Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06139666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*